Medicine guide
VANRAFIA
As listed in the register: VANRAFIA
0.75 mg · tablet
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Atrasentan (Atrasentan Hydrochloride)
- Made by
- Novartis Pharmaceuticals Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupHeart, blood pressure and circulationC09XX
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Novartis Pharmaceuticals Canada Inc |
|---|---|
| Active substance | Atrasentan (Atrasentan Hydrochloride) |
| Used in | Heart, blood pressure and circulation |
| Strength | 0.75 mg |
| Form | tablet |
| Classification | C09XX · Heart, blood pressure and circulation |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02569590 |
| DPD drug code | 107182 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.